#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Molecular Mechanisms of Trichothecene Resistance
2-1	4-13	Molecular	abstract[2]	new[2]	_	_
2-2	14-24	Mechanisms	abstract[2]	new[2]	_	_
2-3	25-27	of	abstract[2]	new[2]	_	_
2-4	28-41	Trichothecene	abstract[2]|place|organization[4]	new[2]|new|new[4]	coref|coref|coref|coref	4-1|5-1[7_4]|4-1|5-1[7_4]
2-5	42-52	Resistance	abstract[2]|organization[4]	new[2]|new[4]	_	_

#Text=4.1 .
3-1	53-56	4.1	abstract	new	_	_
3-2	57-58	.	_	_	_	_

#Text=Trichothecene
4-1	59-72	Trichothecene	place	giv	_	_

#Text=Resistance at the Ribosome
5-1	73-83	Resistance	organization[7]	giv[7]	_	_
5-2	84-86	at	organization[7]	giv[7]	_	_
5-3	87-90	the	organization[7]|place[8]	giv[7]|new[8]	coref	6-9[10_8]
5-4	91-99	Ribosome	organization[7]|place[8]	giv[7]|new[8]	_	_

#Text=Owing to the ubiquitous and essential activities of the ribosome , its structure is highly conserved within phylogenetic domains , making it a reliable target for pathogens .
6-1	100-105	Owing	_	_	_	_
6-2	106-108	to	_	_	_	_
6-3	109-112	the	abstract[9]	new[9]	_	_
6-4	113-123	ubiquitous	abstract[9]	new[9]	_	_
6-5	124-127	and	abstract[9]	new[9]	_	_
6-6	128-137	essential	abstract[9]	new[9]	_	_
6-7	138-148	activities	abstract[9]	new[9]	_	_
6-8	149-151	of	abstract[9]	new[9]	_	_
6-9	152-155	the	abstract[9]|object[10]	new[9]|giv[10]	ana	6-12[0_10]
6-10	156-164	ribosome	abstract[9]|object[10]	new[9]|giv[10]	_	_
6-11	165-166	,	_	_	_	_
6-12	167-170	its	object|abstract[12]	giv|new[12]	ana|ana	6-22|6-22
6-13	171-180	structure	abstract[12]	new[12]	_	_
6-14	181-183	is	_	_	_	_
6-15	184-190	highly	_	_	_	_
6-16	191-200	conserved	_	_	_	_
6-17	201-207	within	_	_	_	_
6-18	208-220	phylogenetic	abstract[13]	new[13]	_	_
6-19	221-228	domains	abstract[13]	new[13]	_	_
6-20	229-230	,	_	_	_	_
6-21	231-237	making	_	_	_	_
6-22	238-240	it	object	giv	coref	7-1[16_0]
6-23	241-242	a	_	_	_	_
6-24	243-251	reliable	_	_	_	_
6-25	252-258	target	_	_	_	_
6-26	259-262	for	_	_	_	_
6-27	263-272	pathogens	animal	new	_	_
6-28	273-274	.	_	_	_	_

#Text=The ribosome can resist the effect of trichothecenes if a point mutation occurs at the tryptophan ( W ) residue within the highly conserved W-finger of Ribosomal Protein L3 ( RPL3 ) .
7-1	275-278	The	object[16]	giv[16]	coref	20-15[160_16]
7-2	279-287	ribosome	object[16]	giv[16]	_	_
7-3	288-291	can	_	_	_	_
7-4	292-298	resist	_	_	_	_
7-5	299-302	the	abstract[17]	new[17]	coref	14-20[91_17]
7-6	303-309	effect	abstract[17]	new[17]	_	_
7-7	310-312	of	abstract[17]	new[17]	_	_
7-8	313-327	trichothecenes	abstract[17]|substance	new[17]|new	_	_
7-9	328-330	if	_	_	_	_
7-10	331-332	a	abstract[20]	new[20]	coref	11-16[62_20]
7-11	333-338	point	abstract|abstract[20]	new|new[20]	_	_
7-12	339-347	mutation	abstract[20]	new[20]	_	_
7-13	348-354	occurs	_	_	_	_
7-14	355-357	at	_	_	_	_
7-15	358-361	the	substance[21]	new[21]	coref	10-6[51_21]
7-16	362-372	tryptophan	substance[21]	new[21]	_	_
7-17	373-374	(	_	_	_	_
7-18	375-376	W	person	new	_	_
7-19	377-378	)	_	_	_	_
7-20	379-386	residue	abstract[23]	new[23]	_	_
7-21	387-393	within	abstract[23]	new[23]	_	_
7-22	394-397	the	abstract[23]|abstract[24]	new[23]|new[24]	coref	9-2[0_24]
7-23	398-404	highly	abstract[23]|abstract[24]	new[23]|new[24]	_	_
7-24	405-414	conserved	abstract[23]|abstract[24]	new[23]|new[24]	_	_
7-25	415-423	W-finger	abstract[23]|abstract[24]	new[23]|new[24]	_	_
7-26	424-426	of	abstract[23]|abstract[24]	new[23]|new[24]	_	_
7-27	427-436	Ribosomal	abstract[23]|abstract[24]|abstract[26]	new[23]|new[24]|new[26]	appos	7-31[0_26]
7-28	437-444	Protein	abstract[23]|abstract[24]|substance|abstract[26]	new[23]|new[24]|new|new[26]	coref	9-10[41_0]
7-29	445-447	L3	abstract[23]|abstract[24]|abstract[26]	new[23]|new[24]|new[26]	_	_
7-30	448-449	(	_	_	_	_
7-31	450-454	RPL3	abstract	giv	coref	9-11
7-32	455-456	)	_	_	_	_
7-33	457-458	.	_	_	_	_

#Text=Mutations at this site also confer resistance to other “ antibiotics ” [ e. g. , anisomycin , 211 ] , that bind the A-site of the peptidyl transferase center .
8-1	459-468	Mutations	abstract[28]	new[28]	coref	12-6[68_28]
8-2	469-471	at	abstract[28]	new[28]	_	_
8-3	472-476	this	abstract[28]|abstract[29]	new[28]|new[29]	coref	9-6[39_29]
8-4	477-481	site	abstract[28]|abstract[29]	new[28]|new[29]	_	_
8-5	482-486	also	_	_	_	_
8-6	487-493	confer	_	_	_	_
8-7	494-504	resistance	abstract	new	coref	12-12
8-8	505-507	to	_	_	_	_
8-9	508-513	other	substance[31]	new[31]	_	_
8-10	514-515	“	substance[31]	new[31]	_	_
8-11	516-527	antibiotics	substance[31]	new[31]	_	_
8-12	528-529	”	substance[31]	new[31]	_	_
8-13	530-531	[	_	_	_	_
8-14	532-534	e.	_	_	_	_
8-15	535-537	g.	_	_	_	_
8-16	538-539	,	_	_	_	_
8-17	540-550	anisomycin	substance[32]	new[32]	_	_
8-18	551-552	,	substance[32]	new[32]	_	_
8-19	553-556	211	substance[32]	new[32]	_	_
8-20	557-558	]	_	_	_	_
8-21	559-560	,	_	_	_	_
8-22	561-565	that	_	_	_	_
8-23	566-570	bind	_	_	_	_
8-24	571-574	the	place[33]	new[33]	_	_
8-25	575-581	A-site	place[33]	new[33]	_	_
8-26	582-584	of	place[33]	new[33]	_	_
8-27	585-588	the	place[33]|object[36]	new[33]|new[36]	_	_
8-28	589-597	peptidyl	place[33]|time|object[36]	new[33]|new|new[36]	coref	9-17
8-29	598-609	transferase	place[33]|object|object[36]	new[33]|new|new[36]	_	_
8-30	610-616	center	place[33]|object[36]	new[33]|new[36]	_	_
8-31	617-618	.	_	_	_	_

#Text=The W-finger projects directly into this site , and the RPL3 protein coordinates aa-tRNA accommodation , peptidyl transfer and translocation steps during protein translation .
9-1	619-622	The	abstract[38]	new[38]	_	_
9-2	623-631	W-finger	abstract|abstract[38]	giv|new[38]	coref	12-6
9-3	632-640	projects	abstract[38]	new[38]	_	_
9-4	641-649	directly	abstract[38]	new[38]	_	_
9-5	650-654	into	abstract[38]	new[38]	_	_
9-6	655-659	this	abstract[38]|place[39]	new[38]|giv[39]	_	_
9-7	660-664	site	abstract[38]|place[39]	new[38]|giv[39]	_	_
9-8	665-666	,	_	_	_	_
9-9	667-670	and	_	_	_	_
9-10	671-674	the	substance[41]	giv[41]	coref	9-23[0_41]
9-11	675-679	RPL3	abstract|substance[41]	giv|giv[41]	coref	13-4[82_0]
9-12	680-687	protein	substance[41]	giv[41]	_	_
9-13	688-699	coordinates	_	_	_	_
9-14	700-707	aa-tRNA	place|event[43]	new|new[43]	coref|ana|coref|ana	11-12|11-21[0_43]|11-12|11-21[0_43]
9-15	708-721	accommodation	event[43]	new[43]	_	_
9-16	722-723	,	_	_	_	_
9-17	724-732	peptidyl	abstract|abstract[45]	giv|new[45]	_	_
9-18	733-741	transfer	abstract[45]	new[45]	_	_
9-19	742-745	and	_	_	_	_
9-20	746-759	translocation	place|abstract[47]	new|new[47]	_	_
9-21	760-765	steps	abstract[47]	new[47]	_	_
9-22	766-772	during	abstract[47]	new[47]	_	_
9-23	773-780	protein	abstract[47]|substance|abstract[49]	new[47]|giv|new[49]	coref|coref|coref|coref	11-26[0_49]|19-18[145_0]|11-26[0_49]|19-18[145_0]
9-24	781-792	translation	abstract[47]|abstract[49]	new[47]|new[49]	_	_
9-25	793-794	.	_	_	_	_

#Text=Only a few substitutions of the tryptophan in this position are viable , including substitutions with other aromatic residues , or with cysteine or arginine .
10-1	795-799	Only	_	_	_	_
10-2	800-801	a	abstract[50]	new[50]	_	_
10-3	802-805	few	abstract[50]	new[50]	_	_
10-4	806-819	substitutions	abstract[50]	new[50]	_	_
10-5	820-822	of	abstract[50]	new[50]	_	_
10-6	823-826	the	abstract[50]|substance[51]	new[50]|giv[51]	_	_
10-7	827-837	tryptophan	abstract[50]|substance[51]	new[50]|giv[51]	_	_
10-8	838-840	in	abstract[50]|substance[51]	new[50]|giv[51]	_	_
10-9	841-845	this	abstract[50]|substance[51]|abstract[52]	new[50]|giv[51]|new[52]	_	_
10-10	846-854	position	abstract[50]|substance[51]|abstract[52]	new[50]|giv[51]|new[52]	_	_
10-11	855-858	are	_	_	_	_
10-12	859-865	viable	_	_	_	_
10-13	866-867	,	_	_	_	_
10-14	868-877	including	_	_	_	_
10-15	878-891	substitutions	abstract[53]	new[53]	_	_
10-16	892-896	with	abstract[53]	new[53]	_	_
10-17	897-902	other	abstract[53]|substance[54]	new[53]|new[54]	_	_
10-18	903-911	aromatic	abstract[53]|substance[54]	new[53]|new[54]	_	_
10-19	912-920	residues	abstract[53]|substance[54]	new[53]|new[54]	_	_
10-20	921-922	,	_	_	_	_
10-21	923-925	or	_	_	_	_
10-22	926-930	with	_	_	_	_
10-23	931-939	cysteine	substance	new	_	_
10-24	940-942	or	_	_	_	_
10-25	943-951	arginine	substance	new	_	_
10-26	952-953	.	_	_	_	_

#Text=Studies in yeast show that the W255C substitution increases affinity to aa-tRNA , and while this mutation is non-lethal , it does result in reduced translation efficiency .
11-1	954-961	Studies	abstract[57]	new[57]	_	_
11-2	962-964	in	abstract[57]	new[57]	_	_
11-3	965-970	yeast	abstract[57]|substance	new[57]|new	coref	15-27
11-4	971-975	show	_	_	_	_
11-5	976-980	that	_	_	_	_
11-6	981-984	the	abstract[59]	new[59]	_	_
11-7	985-990	W255C	abstract[59]	new[59]	_	_
11-8	991-1003	substitution	abstract[59]	new[59]	_	_
11-9	1004-1013	increases	_	_	_	_
11-10	1014-1022	affinity	abstract[60]	new[60]	_	_
11-11	1023-1025	to	abstract[60]	new[60]	_	_
11-12	1026-1033	aa-tRNA	abstract[60]|substance	new[60]|giv	_	_
11-13	1034-1035	,	_	_	_	_
11-14	1036-1039	and	_	_	_	_
11-15	1040-1045	while	_	_	_	_
11-16	1046-1050	this	abstract[62]	giv[62]	_	_
11-17	1051-1059	mutation	abstract[62]	giv[62]	_	_
11-18	1060-1062	is	_	_	_	_
11-19	1063-1073	non-lethal	_	_	_	_
11-20	1074-1075	,	_	_	_	_
11-21	1076-1078	it	event	giv	_	_
11-22	1079-1083	does	_	_	_	_
11-23	1084-1090	result	_	_	_	_
11-24	1091-1093	in	_	_	_	_
11-25	1094-1101	reduced	abstract[65]	new[65]	ana	12-1[0_65]
11-26	1102-1113	translation	abstract|abstract[65]	giv|new[65]	coref	12-20
11-27	1114-1124	efficiency	abstract[65]	new[65]	_	_
11-28	1125-1126	.	_	_	_	_

#Text=It is not known whether W-finger mutations occur as a natural resistance mechanism in plants , although in vitro translation assays demonstrated that ribosomes isolated from the FHB-resistant cultivar , Frontana , exhibit a higher tolerance to DON than those isolated from the susceptible cultivar Cassavant .
12-1	1127-1129	It	abstract	giv	_	_
12-2	1130-1132	is	_	_	_	_
12-3	1133-1136	not	_	_	_	_
12-4	1137-1142	known	_	_	_	_
12-5	1143-1150	whether	_	_	_	_
12-6	1151-1159	W-finger	abstract|abstract[68]	giv|giv[68]	coref|coref	14-13[89_0]|14-13[89_0]
12-7	1160-1169	mutations	abstract[68]	giv[68]	_	_
12-8	1170-1175	occur	_	_	_	_
12-9	1176-1178	as	_	_	_	_
12-10	1179-1180	a	_	_	_	_
12-11	1181-1188	natural	_	_	_	_
12-12	1189-1199	resistance	abstract	giv	coref	16-24[111_0]
12-13	1200-1209	mechanism	_	_	_	_
12-14	1210-1212	in	_	_	_	_
12-15	1213-1219	plants	plant	new	coref	15-3[95_0]
12-16	1220-1221	,	_	_	_	_
12-17	1222-1230	although	_	_	_	_
12-18	1231-1233	in	_	_	_	_
12-19	1234-1239	vitro	place[72]	new[72]	_	_
12-20	1240-1251	translation	abstract|place[72]	giv|new[72]	coref	23-54
12-21	1252-1258	assays	place[72]	new[72]	_	_
12-22	1259-1271	demonstrated	_	_	_	_
12-23	1272-1276	that	_	_	_	_
12-24	1277-1286	ribosomes	object	new	coref	23-43[201_0]
12-25	1287-1295	isolated	_	_	_	_
12-26	1296-1300	from	_	_	_	_
12-27	1301-1304	the	plant[75]	new[75]	coref	12-44[79_75]
12-28	1305-1318	FHB-resistant	person|plant[75]	new|new[75]	_	_
12-29	1319-1327	cultivar	plant[75]	new[75]	_	_
12-30	1328-1329	,	_	_	_	_
12-31	1330-1338	Frontana	object	new	_	_
12-32	1339-1340	,	_	_	_	_
12-33	1341-1348	exhibit	_	_	_	_
12-34	1349-1350	a	abstract[77]	new[77]	coref	16-15[107_77]
12-35	1351-1357	higher	abstract[77]	new[77]	_	_
12-36	1358-1367	tolerance	abstract[77]	new[77]	_	_
12-37	1368-1370	to	abstract[77]	new[77]	_	_
12-38	1371-1374	DON	abstract[77]|place[78]	new[77]|new[78]	coref	14-31[0_78]
12-39	1375-1379	than	abstract[77]|place[78]	new[77]|new[78]	_	_
12-40	1380-1385	those	abstract[77]|place[78]	new[77]|new[78]	_	_
12-41	1386-1394	isolated	_	_	_	_
12-42	1395-1399	from	_	_	_	_
12-43	1400-1403	the	object[80]	new[80]	_	_
12-44	1404-1415	susceptible	plant[79]|object[80]	giv[79]|new[80]	_	_
12-45	1416-1424	cultivar	plant[79]|object[80]	giv[79]|new[80]	_	_
12-46	1425-1434	Cassavant	object[80]	new[80]	_	_
12-47	1435-1436	.	_	_	_	_

#Text=Transgenic expression of modified RPL3 has had mixed results .
13-1	1437-1447	Transgenic	abstract[81]	new[81]	ana	14-1[0_81]
13-2	1448-1458	expression	abstract[81]	new[81]	_	_
13-3	1459-1461	of	abstract[81]	new[81]	_	_
13-4	1462-1470	modified	abstract[81]|abstract[82]	new[81]|giv[82]	coref	14-10[0_82]
13-5	1471-1475	RPL3	abstract[81]|abstract[82]	new[81]|giv[82]	_	_
13-6	1476-1479	has	_	_	_	_
13-7	1480-1483	had	_	_	_	_
13-8	1484-1489	mixed	abstract[83]	new[83]	_	_
13-9	1490-1497	results	abstract[83]	new[83]	_	_
13-10	1498-1499	.	_	_	_	_

#Text=It was determined that the expression of the tomato RPL3 gene with a modified W-finger ( W258C ) had a minimal effect on the ability of transgenic tobacco to tolerate DON .
14-1	1500-1502	It	abstract	giv	_	_
14-2	1503-1506	was	_	_	_	_
14-3	1507-1517	determined	_	_	_	_
14-4	1518-1522	that	_	_	_	_
14-5	1523-1526	the	abstract[85]	new[85]	_	_
14-6	1527-1537	expression	abstract[85]	new[85]	_	_
14-7	1538-1540	of	abstract[85]	new[85]	_	_
14-8	1541-1544	the	abstract[85]|abstract[86]	new[85]|new[86]	_	_
14-9	1545-1551	tomato	abstract[85]|abstract[86]	new[85]|new[86]	_	_
14-10	1552-1556	RPL3	abstract[85]|abstract|abstract[88]	new[85]|giv|new[88]	coref|coref|coref|coref	15-10[97_0]|18-25[132_88]|15-10[97_0]|18-25[132_88]
14-11	1557-1561	gene	abstract[85]|abstract[88]	new[85]|new[88]	_	_
14-12	1562-1566	with	abstract[85]	new[85]	_	_
14-13	1567-1568	a	abstract[85]|abstract[89]	new[85]|giv[89]	appos	14-17[0_89]
14-14	1569-1577	modified	abstract[85]|abstract[89]	new[85]|giv[89]	_	_
14-15	1578-1586	W-finger	abstract[85]|abstract[89]	new[85]|giv[89]	_	_
14-16	1587-1588	(	_	_	_	_
14-17	1589-1594	W258C	abstract	giv	_	_
14-18	1595-1596	)	_	_	_	_
14-19	1597-1600	had	_	_	_	_
14-20	1601-1602	a	abstract[91]	giv[91]	_	_
14-21	1603-1610	minimal	abstract[91]	giv[91]	_	_
14-22	1611-1617	effect	abstract[91]	giv[91]	_	_
14-23	1618-1620	on	abstract[91]	giv[91]	_	_
14-24	1621-1624	the	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
14-25	1625-1632	ability	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
14-26	1633-1635	of	abstract[91]|abstract[92]	giv[91]|new[92]	_	_
14-27	1636-1646	transgenic	abstract[91]|abstract[92]|substance[93]	giv[91]|new[92]|new[93]	coref	16-18[0_93]
14-28	1647-1654	tobacco	abstract[91]|abstract[92]|substance[93]	giv[91]|new[92]|new[93]	_	_
14-29	1655-1657	to	_	_	_	_
14-30	1658-1666	tolerate	_	_	_	_
14-31	1667-1670	DON	place	giv	coref	15-19
14-32	1671-1672	.	_	_	_	_

#Text=Additionally , transgenic plants were found to preferentially utilize the wild-type RPL3 ( except at sub-lethal concentrations of DON ) and these observations were corroborated using yeast transformants .
15-1	1673-1685	Additionally	_	_	_	_
15-2	1686-1687	,	_	_	_	_
15-3	1688-1698	transgenic	plant[95]	giv[95]	coref	18-31[133_95]
15-4	1699-1705	plants	plant[95]	giv[95]	_	_
15-5	1706-1710	were	_	_	_	_
15-6	1711-1716	found	_	_	_	_
15-7	1717-1719	to	_	_	_	_
15-8	1720-1734	preferentially	_	_	_	_
15-9	1735-1742	utilize	_	_	_	_
15-10	1743-1746	the	abstract[97]	giv[97]	coref	16-9[105_97]
15-11	1747-1756	wild-type	abstract|abstract[97]	new|giv[97]	coref	17-32
15-12	1757-1761	RPL3	abstract[97]	giv[97]	_	_
15-13	1762-1763	(	_	_	_	_
15-14	1764-1770	except	_	_	_	_
15-15	1771-1773	at	_	_	_	_
15-16	1774-1784	sub-lethal	abstract[98]	new[98]	_	_
15-17	1785-1799	concentrations	abstract[98]	new[98]	_	_
15-18	1800-1802	of	abstract[98]	new[98]	_	_
15-19	1803-1806	DON	abstract[98]|quantity	new[98]|giv	coref	16-15
15-20	1807-1808	)	_	_	_	_
15-21	1809-1812	and	_	_	_	_
15-22	1813-1818	these	abstract[100]	new[100]	_	_
15-23	1819-1831	observations	abstract[100]	new[100]	_	_
15-24	1832-1836	were	_	_	_	_
15-25	1837-1849	corroborated	_	_	_	_
15-26	1850-1855	using	_	_	_	_
15-27	1856-1861	yeast	substance|abstract[102]	giv|new[102]	coref|coref	17-17|17-17
15-28	1862-1875	transformants	abstract[102]	new[102]	_	_
15-29	1876-1877	.	_	_	_	_

#Text=On the other hand , transgenic expression of a W258C modified rice RPL3 conferred DON tolerance in tobacco protoplasts , as well as FEB resistance in maize .
16-1	1878-1880	On	_	_	_	_
16-2	1881-1884	the	_	_	_	_
16-3	1885-1890	other	_	_	_	_
16-4	1891-1895	hand	_	_	_	_
16-5	1896-1897	,	_	_	_	_
16-6	1898-1908	transgenic	abstract[103]	new[103]	_	_
16-7	1909-1919	expression	abstract[103]	new[103]	_	_
16-8	1920-1922	of	abstract[103]	new[103]	_	_
16-9	1923-1924	a	abstract[103]|abstract[105]	new[103]|giv[105]	coref	17-13[115_105]
16-10	1925-1930	W258C	abstract[103]|abstract[105]	new[103]|giv[105]	_	_
16-11	1931-1939	modified	abstract[103]|abstract[105]	new[103]|giv[105]	_	_
16-12	1940-1944	rice	abstract[103]|substance|abstract[105]	new[103]|new|giv[105]	_	_
16-13	1945-1949	RPL3	abstract[103]|abstract[105]	new[103]|giv[105]	_	_
16-14	1950-1959	conferred	_	_	_	_
16-15	1960-1963	DON	place|abstract[107]	giv|giv[107]	coref|coref|coref|coref	17-20|19-43[155_107]|17-20|19-43[155_107]
16-16	1964-1973	tolerance	abstract[107]	giv[107]	_	_
16-17	1974-1976	in	abstract[107]	giv[107]	_	_
16-18	1977-1984	tobacco	abstract[107]|substance|object[109]	giv[107]|giv|new[109]	coref|coref	19-26|19-26
16-19	1985-1996	protoplasts	abstract[107]|object[109]	giv[107]|new[109]	_	_
16-20	1997-1998	,	_	_	_	_
16-21	1999-2001	as	_	_	_	_
16-22	2002-2006	well	_	_	_	_
16-23	2007-2009	as	_	_	_	_
16-24	2010-2013	FEB	event|abstract[111]	new|giv[111]	ana|ana	17-1[0_111]|17-1[0_111]
16-25	2014-2024	resistance	abstract[111]	giv[111]	_	_
16-26	2025-2027	in	abstract[111]	giv[111]	_	_
16-27	2028-2033	maize	abstract[111]|plant	giv[111]|new	_	_
16-28	2034-2035	.	_	_	_	_

#Text=It has also been suggested by Di et al. that expression of a truncated RPL3 from yeast could reduce DON toxicity in cereals by drawing the toxin away from the functional wild-type RPL3 .
17-1	2036-2038	It	abstract	giv	coref	21-37[176_0]
17-2	2039-2042	has	_	_	_	_
17-3	2043-2047	also	_	_	_	_
17-4	2048-2052	been	_	_	_	_
17-5	2053-2062	suggested	_	_	_	_
17-6	2063-2065	by	_	_	_	_
17-7	2066-2068	Di	_	_	_	_
17-8	2069-2071	et	_	_	_	_
17-9	2072-2075	al.	_	_	_	_
17-10	2076-2080	that	abstract[114]	new[114]	_	_
17-11	2081-2091	expression	abstract[114]	new[114]	_	_
17-12	2092-2094	of	abstract[114]	new[114]	_	_
17-13	2095-2096	a	abstract[114]|abstract[115]	new[114]|giv[115]	coref	17-30[122_115]
17-14	2097-2106	truncated	abstract[114]|abstract[115]	new[114]|giv[115]	_	_
17-15	2107-2111	RPL3	abstract[114]|abstract[115]	new[114]|giv[115]	_	_
17-16	2112-2116	from	abstract[114]|abstract[115]	new[114]|giv[115]	_	_
17-17	2117-2122	yeast	abstract[114]|abstract[115]|animal	new[114]|giv[115]|giv	coref	18-5
17-18	2123-2128	could	_	_	_	_
17-19	2129-2135	reduce	_	_	_	_
17-20	2136-2139	DON	place|abstract[118]	giv|new[118]	coref|coref	18-42|18-42
17-21	2140-2148	toxicity	abstract[118]	new[118]	_	_
17-22	2149-2151	in	_	_	_	_
17-23	2152-2159	cereals	plant	new	_	_
17-24	2160-2162	by	_	_	_	_
17-25	2163-2170	drawing	_	_	_	_
17-26	2171-2174	the	substance[120]	new[120]	coref	24-28[214_120]
17-27	2175-2180	toxin	substance[120]	new[120]	_	_
17-28	2181-2185	away	_	_	_	_
17-29	2186-2190	from	_	_	_	_
17-30	2191-2194	the	abstract[122]	giv[122]	coref	18-4[125_122]
17-31	2195-2205	functional	abstract[122]	giv[122]	_	_
17-32	2206-2215	wild-type	abstract|abstract[122]	giv|giv[122]	_	_
17-33	2216-2220	RPL3	abstract[122]	giv[122]	_	_
17-34	2221-2222	.	_	_	_	_

#Text=The authors expressed truncated yeast RPL3 ( ΔL3 ) in wheat and found that , in addition to an increase in the expression of the endogenous wheat RPL3 gene , transgenic plants displayed a reduction in FHB symptoms as well as DON accumulation .
18-1	2223-2226	The	person[123]	new[123]	_	_
18-2	2227-2234	authors	person[123]	new[123]	_	_
18-3	2235-2244	expressed	_	_	_	_
18-4	2245-2254	truncated	abstract[125]	giv[125]	appos	18-8[0_125]
18-5	2255-2260	yeast	substance|abstract[125]	giv|giv[125]	_	_
18-6	2261-2265	RPL3	abstract[125]	giv[125]	_	_
18-7	2266-2267	(	_	_	_	_
18-8	2268-2271	ΔL3	abstract	giv	coref	18-28
18-9	2272-2273	)	_	_	_	_
18-10	2274-2276	in	_	_	_	_
18-11	2277-2282	wheat	plant	new	coref	18-26[130_0]
18-12	2283-2286	and	_	_	_	_
18-13	2287-2292	found	_	_	_	_
18-14	2293-2297	that	_	_	_	_
18-15	2298-2299	,	_	_	_	_
18-16	2300-2302	in	_	_	_	_
18-17	2303-2311	addition	_	_	_	_
18-18	2312-2314	to	_	_	_	_
18-19	2315-2317	an	abstract[128]	new[128]	_	_
18-20	2318-2326	increase	abstract[128]	new[128]	_	_
18-21	2327-2329	in	abstract[128]	new[128]	_	_
18-22	2330-2333	the	abstract[128]|abstract[129]	new[128]|new[129]	_	_
18-23	2334-2344	expression	abstract[128]|abstract[129]	new[128]|new[129]	_	_
18-24	2345-2347	of	abstract[128]|abstract[129]	new[128]|new[129]	_	_
18-25	2348-2351	the	abstract[128]|abstract[129]|abstract[132]	new[128]|new[129]|giv[132]	coref	19-35[152_132]
18-26	2352-2362	endogenous	abstract[128]|abstract[129]|plant[130]|abstract[132]	new[128]|new[129]|giv[130]|giv[132]	coref	20-28[0_130]
18-27	2363-2368	wheat	abstract[128]|abstract[129]|plant[130]|abstract[132]	new[128]|new[129]|giv[130]|giv[132]	_	_
18-28	2369-2373	RPL3	abstract[128]|abstract[129]|person|abstract[132]	new[128]|new[129]|giv|giv[132]	coref	19-15[142_0]
18-29	2374-2378	gene	abstract[128]|abstract[129]|abstract[132]	new[128]|new[129]|giv[132]	_	_
18-30	2379-2380	,	_	_	_	_
18-31	2381-2391	transgenic	plant[133]	giv[133]	_	_
18-32	2392-2398	plants	plant[133]	giv[133]	_	_
18-33	2399-2408	displayed	_	_	_	_
18-34	2409-2410	a	abstract[134]	new[134]	_	_
18-35	2411-2420	reduction	abstract[134]	new[134]	_	_
18-36	2421-2423	in	abstract[134]	new[134]	_	_
18-37	2424-2427	FHB	abstract[134]|abstract|abstract[136]	new[134]|new|new[136]	_	_
18-38	2428-2436	symptoms	abstract[134]|abstract[136]	new[134]|new[136]	_	_
18-39	2437-2439	as	_	_	_	_
18-40	2440-2444	well	_	_	_	_
18-41	2445-2447	as	_	_	_	_
18-42	2448-2451	DON	place|abstract[138]	giv|new[138]	coref|coref	19-44|19-44
18-43	2452-2464	accumulation	abstract[138]	new[138]	_	_
18-44	2465-2466	.	_	_	_	_

#Text=In a similar study , the same group had earlier reported that co-expression of ΔL3 together with a Pokeweed Antiviral Protein ( PAP ) in tobacco cells resulted in increased expression of the host RPL3 gene , and this was coincident with improved DON tolerance .
19-1	2467-2469	In	_	_	_	_
19-2	2470-2471	a	abstract[139]	new[139]	coref	21-2[167_139]
19-3	2472-2479	similar	abstract[139]	new[139]	_	_
19-4	2480-2485	study	abstract[139]	new[139]	_	_
19-5	2486-2487	,	_	_	_	_
19-6	2488-2491	the	person[140]	new[140]	_	_
19-7	2492-2496	same	person[140]	new[140]	_	_
19-8	2497-2502	group	person[140]	new[140]	_	_
19-9	2503-2506	had	_	_	_	_
19-10	2507-2514	earlier	_	_	_	_
19-11	2515-2523	reported	_	_	_	_
19-12	2524-2528	that	abstract[141]	new[141]	_	_
19-13	2529-2542	co-expression	abstract[141]	new[141]	_	_
19-14	2543-2545	of	abstract[141]	new[141]	_	_
19-15	2546-2549	ΔL3	abstract[141]|abstract[142]	new[141]|giv[142]	coref	19-35[0_142]
19-16	2550-2558	together	abstract[141]|abstract[142]	new[141]|giv[142]	_	_
19-17	2559-2563	with	abstract[141]|abstract[142]	new[141]|giv[142]	_	_
19-18	2564-2565	a	abstract[141]|abstract[142]|substance[145]	new[141]|giv[142]|giv[145]	_	_
19-19	2566-2574	Pokeweed	abstract[141]|abstract[142]|plant|substance[145]	new[141]|giv[142]|new|giv[145]	_	_
19-20	2575-2584	Antiviral	abstract[141]|abstract[142]|person|substance[145]	new[141]|giv[142]|new|giv[145]	_	_
19-21	2585-2592	Protein	abstract[141]|abstract[142]|substance[145]	new[141]|giv[142]|giv[145]	_	_
19-22	2593-2594	(	_	_	_	_
19-23	2595-2598	PAP	organization	new	_	_
19-24	2599-2600	)	_	_	_	_
19-25	2601-2603	in	_	_	_	_
19-26	2604-2611	tobacco	substance|object[148]	giv|new[148]	_	_
19-27	2612-2617	cells	object[148]	new[148]	_	_
19-28	2618-2626	resulted	_	_	_	_
19-29	2627-2629	in	_	_	_	_
19-30	2630-2639	increased	abstract[149]	new[149]	_	_
19-31	2640-2650	expression	abstract[149]	new[149]	_	_
19-32	2651-2653	of	abstract[149]	new[149]	_	_
19-33	2654-2657	the	abstract[149]|person[150]	new[149]|new[150]	_	_
19-34	2658-2662	host	abstract[149]|person[150]	new[149]|new[150]	_	_
19-35	2663-2667	RPL3	person|abstract[152]	giv|giv[152]	ana|ana	19-39[0_152]|19-39[0_152]
19-36	2668-2672	gene	abstract[152]	giv[152]	_	_
19-37	2673-2674	,	_	_	_	_
19-38	2675-2678	and	_	_	_	_
19-39	2679-2683	this	abstract	giv	coref	23-12
19-40	2684-2687	was	_	_	_	_
19-41	2688-2698	coincident	_	_	_	_
19-42	2699-2703	with	_	_	_	_
19-43	2704-2712	improved	abstract[155]	giv[155]	_	_
19-44	2713-2716	DON	place|abstract[155]	giv|giv[155]	coref	20-25
19-45	2717-2726	tolerance	abstract[155]	giv[155]	_	_
19-46	2727-2728	.	_	_	_	_

#Text=In this context , it is interesting that the up-regulation of different components of the ribosome has been observed directly in response to exogenous DON applications in wheat .
20-1	2729-2731	In	_	_	_	_
20-2	2732-2736	this	abstract[156]	new[156]	_	_
20-3	2737-2744	context	abstract[156]	new[156]	_	_
20-4	2745-2746	,	_	_	_	_
20-5	2747-2749	it	place	new	cata	20-5[0_161]
20-6	2750-2752	is	_	_	_	_
20-7	2753-2764	interesting	_	_	_	_
20-8	2765-2769	that	place[161]	new[161]	_	_
20-9	2770-2773	the	abstract[158]|place[161]	new[158]|new[161]	coref	22-7[178_158]
20-10	2774-2787	up-regulation	abstract[158]|place[161]	new[158]|new[161]	_	_
20-11	2788-2790	of	abstract[158]|place[161]	new[158]|new[161]	_	_
20-12	2791-2800	different	abstract[158]|abstract[159]|place[161]	new[158]|new[159]|new[161]	coref	21-15[171_159]
20-13	2801-2811	components	abstract[158]|abstract[159]|place[161]	new[158]|new[159]|new[161]	_	_
20-14	2812-2814	of	abstract[158]|abstract[159]|place[161]	new[158]|new[159]|new[161]	_	_
20-15	2815-2818	the	abstract[158]|abstract[159]|object[160]|place[161]	new[158]|new[159]|giv[160]|new[161]	coref	23-34[0_160]
20-16	2819-2827	ribosome	abstract[158]|abstract[159]|object[160]|place[161]	new[158]|new[159]|giv[160]|new[161]	_	_
20-17	2828-2831	has	place[161]	new[161]	_	_
20-18	2832-2836	been	place[161]	new[161]	_	_
20-19	2837-2845	observed	place[161]	new[161]	_	_
20-20	2846-2854	directly	place[161]	new[161]	_	_
20-21	2855-2857	in	_	_	_	_
20-22	2858-2866	response	abstract[162]	new[162]	_	_
20-23	2867-2869	to	abstract[162]	new[162]	_	_
20-24	2870-2879	exogenous	abstract[162]|abstract[164]	new[162]|new[164]	_	_
20-25	2880-2883	DON	abstract[162]|place|abstract[164]	new[162]|giv|new[164]	coref	21-10
20-26	2884-2896	applications	abstract[162]|abstract[164]	new[162]|new[164]	_	_
20-27	2897-2899	in	abstract[162]|abstract[164]	new[162]|new[164]	_	_
20-28	2900-2905	wheat	abstract[162]|abstract[164]|plant	new[162]|new[164]|giv	_	_
20-29	2906-2907	.	_	_	_	_

#Text=In a transcriptomics study by Foroud et al. , DON induced higher expression of ribosomal components , but only in the resistant genotypes , which incidentally were generated through a process that provides selection pressure for trichothecene resistance .
21-1	2908-2910	In	_	_	_	_
21-2	2911-2912	a	abstract[167]	giv[167]	_	_
21-3	2913-2928	transcriptomics	abstract|abstract[167]	new|giv[167]	_	_
21-4	2929-2934	study	abstract[167]	giv[167]	_	_
21-5	2935-2937	by	abstract[167]	giv[167]	_	_
21-6	2938-2944	Foroud	abstract[167]|person	giv[167]|new	_	_
21-7	2945-2947	et	abstract[167]	giv[167]	_	_
21-8	2948-2951	al.	abstract[167]	giv[167]	_	_
21-9	2952-2953	,	_	_	_	_
21-10	2954-2957	DON	place	giv	_	_
21-11	2958-2965	induced	_	_	_	_
21-12	2966-2972	higher	abstract[170]	new[170]	coref	22-33[0_170]
21-13	2973-2983	expression	abstract[170]	new[170]	_	_
21-14	2984-2986	of	abstract[170]	new[170]	_	_
21-15	2987-2996	ribosomal	abstract[170]|abstract[171]	new[170]|giv[171]	_	_
21-16	2997-3007	components	abstract[170]|abstract[171]	new[170]|giv[171]	_	_
21-17	3008-3009	,	_	_	_	_
21-18	3010-3013	but	_	_	_	_
21-19	3014-3018	only	abstract[172]	new[172]	coref	22-38[188_172]
21-20	3019-3021	in	abstract[172]	new[172]	_	_
21-21	3022-3025	the	abstract[172]	new[172]	_	_
21-22	3026-3035	resistant	abstract[172]	new[172]	_	_
21-23	3036-3045	genotypes	abstract[172]	new[172]	_	_
21-24	3046-3047	,	_	_	_	_
21-25	3048-3053	which	_	_	_	_
21-26	3054-3066	incidentally	_	_	_	_
21-27	3067-3071	were	_	_	_	_
21-28	3072-3081	generated	_	_	_	_
21-29	3082-3089	through	_	_	_	_
21-30	3090-3091	a	abstract[173]	new[173]	_	_
21-31	3092-3099	process	abstract[173]	new[173]	_	_
21-32	3100-3104	that	_	_	_	_
21-33	3105-3113	provides	_	_	_	_
21-34	3114-3123	selection	abstract|abstract[175]	new|new[175]	_	_
21-35	3124-3132	pressure	abstract[175]	new[175]	_	_
21-36	3133-3136	for	abstract[175]	new[175]	_	_
21-37	3137-3150	trichothecene	abstract[175]|abstract[176]	new[175]|giv[176]	coref	22-36[187_176]
21-38	3151-3161	resistance	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
21-39	3162-3163	.	_	_	_	_

#Text=There are many potential explanations for this up-regulation , though at this stage only speculation can be offered , and it is also unknown whether there is a direct link with this expression pattern and resistance in these genotypes .
22-1	3164-3169	There	_	_	_	_
22-2	3170-3173	are	_	_	_	_
22-3	3174-3178	many	abstract[177]	new[177]	_	_
22-4	3179-3188	potential	abstract[177]	new[177]	_	_
22-5	3189-3201	explanations	abstract[177]	new[177]	_	_
22-6	3202-3205	for	abstract[177]	new[177]	_	_
22-7	3206-3210	this	abstract[177]|abstract[178]	new[177]|giv[178]	_	_
22-8	3211-3224	up-regulation	abstract[177]|abstract[178]	new[177]|giv[178]	_	_
22-9	3225-3226	,	_	_	_	_
22-10	3227-3233	though	abstract[181]	new[181]	_	_
22-11	3234-3236	at	abstract[181]	new[181]	_	_
22-12	3237-3241	this	abstract[179]|abstract[181]	new[179]|new[181]	_	_
22-13	3242-3247	stage	abstract[179]|abstract[181]	new[179]|new[181]	_	_
22-14	3248-3252	only	abstract[180]|abstract[181]	new[180]|new[181]	_	_
22-15	3253-3264	speculation	abstract[180]|abstract[181]	new[180]|new[181]	_	_
22-16	3265-3268	can	abstract[181]	new[181]	_	_
22-17	3269-3271	be	abstract[181]	new[181]	_	_
22-18	3272-3279	offered	abstract[181]	new[181]	_	_
22-19	3280-3281	,	_	_	_	_
22-20	3282-3285	and	_	_	_	_
22-21	3286-3288	it	abstract	new	cata	22-21[0_183]
22-22	3289-3291	is	_	_	_	_
22-23	3292-3296	also	_	_	_	_
22-24	3297-3304	unknown	_	_	_	_
22-25	3305-3312	whether	abstract[183]	new[183]	_	_
22-26	3313-3318	there	abstract[183]	new[183]	_	_
22-27	3319-3321	is	abstract[183]	new[183]	_	_
22-28	3322-3323	a	abstract[184]	new[184]	_	_
22-29	3324-3330	direct	abstract[184]	new[184]	_	_
22-30	3331-3335	link	abstract[184]	new[184]	_	_
22-31	3336-3340	with	abstract[184]	new[184]	_	_
22-32	3341-3345	this	abstract[184]|abstract[186]	new[184]|new[186]	_	_
22-33	3346-3356	expression	abstract[184]|abstract|abstract[186]	new[184]|giv|new[186]	coref	23-11[192_0]
22-34	3357-3364	pattern	abstract[184]|abstract[186]	new[184]|new[186]	_	_
22-35	3365-3368	and	abstract[184]	new[184]	_	_
22-36	3369-3379	resistance	abstract[184]|abstract[187]	new[184]|giv[187]	ana	23-1[0_187]
22-37	3380-3382	in	abstract[184]|abstract[187]	new[184]|giv[187]	_	_
22-38	3383-3388	these	abstract[184]|abstract[187]|abstract[188]	new[184]|giv[187]|giv[188]	_	_
22-39	3389-3398	genotypes	abstract[184]|abstract[187]|abstract[188]	new[184]|giv[187]|giv[188]	_	_
22-40	3399-3400	.	_	_	_	_

#Text=It should be noted , however , that changes in ribosomal gene expression have been reported in different plant-pathogen interactions ( e. g. , ) , and importantly , according to the ‘ ribosome filter hypothesis ’ alterations in ribosomal composition or specialized ribosomes are thought to bias incorporation of specific mRNAs to translation .
23-1	3401-3403	It	abstract	giv	coref	24-25[213_0]
23-2	3404-3410	should	_	_	_	_
23-3	3411-3413	be	_	_	_	_
23-4	3414-3419	noted	_	_	_	_
23-5	3420-3421	,	_	_	_	_
23-6	3422-3429	however	_	_	_	_
23-7	3430-3431	,	_	_	_	_
23-8	3432-3436	that	abstract[190]	new[190]	coref	24-10[208_190]
23-9	3437-3444	changes	abstract[190]	new[190]	_	_
23-10	3445-3447	in	abstract[190]	new[190]	_	_
23-11	3448-3457	ribosomal	abstract[190]|abstract[192]	new[190]|giv[192]	coref	24-15[211_192]
23-12	3458-3462	gene	abstract[190]|abstract|abstract[192]	new[190]|giv|giv[192]	coref	24-16
23-13	3463-3473	expression	abstract[190]|abstract[192]	new[190]|giv[192]	_	_
23-14	3474-3478	have	_	_	_	_
23-15	3479-3483	been	_	_	_	_
23-16	3484-3492	reported	_	_	_	_
23-17	3493-3495	in	_	_	_	_
23-18	3496-3505	different	abstract[193]	new[193]	_	_
23-19	3506-3520	plant-pathogen	abstract[193]	new[193]	_	_
23-20	3521-3533	interactions	abstract[193]	new[193]	_	_
23-21	3534-3535	(	_	_	_	_
23-22	3536-3538	e.	_	_	_	_
23-23	3539-3541	g.	abstract	new	_	_
23-24	3542-3543	,	_	_	_	_
23-25	3544-3545	)	_	_	_	_
23-26	3546-3547	,	_	_	_	_
23-27	3548-3551	and	_	_	_	_
23-28	3552-3563	importantly	_	_	_	_
23-29	3564-3565	,	_	_	_	_
23-30	3566-3575	according	_	_	_	_
23-31	3576-3578	to	_	_	_	_
23-32	3579-3582	the	abstract[198]	new[198]	_	_
23-33	3583-3584	‘	abstract[197]|abstract[198]	new[197]|new[198]	coref	24-3[206_197]
23-34	3585-3593	ribosome	object|abstract[197]|abstract[198]	giv|new[197]|new[198]	_	_
23-35	3594-3600	filter	object|abstract[197]|abstract[198]	new|new[197]|new[198]	coref	24-4
23-36	3601-3611	hypothesis	abstract[197]|abstract[198]	new[197]|new[198]	_	_
23-37	3612-3613	’	abstract[197]|abstract[198]	new[197]|new[198]	_	_
23-38	3614-3625	alterations	abstract[198]	new[198]	_	_
23-39	3626-3628	in	abstract[198]	new[198]	_	_
23-40	3629-3638	ribosomal	abstract[198]|animal|abstract[200]	new[198]|new|new[200]	coref|coref	24-15|24-15
23-41	3639-3650	composition	abstract[198]|abstract[200]	new[198]|new[200]	_	_
23-42	3651-3653	or	abstract[198]	new[198]	_	_
23-43	3654-3665	specialized	abstract[198]|object[201]	new[198]|giv[201]	_	_
23-44	3666-3675	ribosomes	abstract[198]|object[201]	new[198]|giv[201]	_	_
23-45	3676-3679	are	_	_	_	_
23-46	3680-3687	thought	_	_	_	_
23-47	3688-3690	to	_	_	_	_
23-48	3691-3695	bias	_	_	_	_
23-49	3696-3709	incorporation	event[202]	new[202]	_	_
23-50	3710-3712	of	event[202]	new[202]	_	_
23-51	3713-3721	specific	event[202]|abstract[203]	new[202]|new[203]	_	_
23-52	3722-3727	mRNAs	event[202]|abstract[203]	new[202]|new[203]	_	_
23-53	3728-3730	to	event[202]|abstract[203]	new[202]|new[203]	_	_
23-54	3731-3742	translation	event[202]|abstract[203]|abstract	new[202]|new[203]|giv	coref	24-20[212_0]
23-55	3743-3744	.	_	_	_	_

#Text=Thus , the filter hypothesis offers the possibility that the reported DON-induced changes in ribosomal gene expression might coordinate defense-related translation rather than conferring ribosomal resistance to the toxin .
24-1	3745-3749	Thus	_	_	_	_
24-2	3750-3751	,	_	_	_	_
24-3	3752-3755	the	abstract[206]	giv[206]	_	_
24-4	3756-3762	filter	object|abstract[206]	giv|giv[206]	_	_
24-5	3763-3773	hypothesis	abstract[206]	giv[206]	_	_
24-6	3774-3780	offers	_	_	_	_
24-7	3781-3784	the	abstract[207]	new[207]	_	_
24-8	3785-3796	possibility	abstract[207]	new[207]	_	_
24-9	3797-3801	that	abstract[207]	new[207]	_	_
24-10	3802-3805	the	abstract[207]|abstract[208]	new[207]|giv[208]	_	_
24-11	3806-3814	reported	abstract[207]|abstract[208]	new[207]|giv[208]	_	_
24-12	3815-3826	DON-induced	abstract[207]|abstract[208]	new[207]|giv[208]	_	_
24-13	3827-3834	changes	abstract[207]|abstract[208]	new[207]|giv[208]	_	_
24-14	3835-3837	in	abstract[207]|abstract[208]	new[207]|giv[208]	_	_
24-15	3838-3847	ribosomal	abstract[207]|abstract[208]|person|abstract[211]	new[207]|giv[208]|giv|giv[211]	_	_
24-16	3848-3852	gene	abstract[207]|abstract[208]|abstract|abstract[211]	new[207]|giv[208]|giv|giv[211]	_	_
24-17	3853-3863	expression	abstract[207]|abstract[208]|abstract[211]	new[207]|giv[208]|giv[211]	_	_
24-18	3864-3869	might	abstract[207]	new[207]	_	_
24-19	3870-3880	coordinate	abstract[207]	new[207]	_	_
24-20	3881-3896	defense-related	abstract[207]|abstract[212]	new[207]|giv[212]	_	_
24-21	3897-3908	translation	abstract[207]|abstract[212]	new[207]|giv[212]	_	_
24-22	3909-3915	rather	_	_	_	_
24-23	3916-3920	than	_	_	_	_
24-24	3921-3931	conferring	_	_	_	_
24-25	3932-3941	ribosomal	abstract[213]	giv[213]	_	_
24-26	3942-3952	resistance	abstract[213]	giv[213]	_	_
24-27	3953-3955	to	abstract[213]	giv[213]	_	_
24-28	3956-3959	the	abstract[213]|substance[214]	giv[213]|giv[214]	_	_
24-29	3960-3965	toxin	abstract[213]|substance[214]	giv[213]|giv[214]	_	_
24-30	3966-3967	.	_	_	_	_
